José Valentín
García Gutiérrez
Profesor/a Asociado/a en CC. de la Salud
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaPublicacions en col·laboració amb investigadors/es de Azienda Ospedaliero-Universitaria Careggi (8)
2024
-
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Annals of Hematology, Vol. 103, Núm. 7, pp. 2299-2310
2022
-
Breakthrough infections in MPN-COVID vaccinated patients
Blood Cancer Journal
-
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19
American Journal of Hematology
-
MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S326-S327
-
Second versus first wave of COVID-19 in patients with MPN
Leukemia
2021
-
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Blood Cancer Journal, Vol. 11, Núm. 2
-
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
Leukemia, Vol. 35, Núm. 2, pp. 485-493
-
Long-term follow-up of recovered MPN patients with COVID-19
Blood Cancer Journal